Vertex Pharmaceuticals (VRTX) Q2 2021 Earnings Report
0 Followers
MX:VRTX Q2 2021 EPS Results
- Actual EPS
- MXN 57.71
- Consensus EPS
- MXN 46.97
- Beat/Miss
- Beat by +MXN 10.74
- One Year Ago EPS
- MXN 48.43
MX:VRTX Q2 2021 Revenue Results
- Actual Revenue
- MXN 33.60B
- Expected Revenue
- MXN 31.89B
- Beat/Miss
- Beat by +MXN 1.72B
- YoY Revenue Growth
- +19.29%
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 07/29/2021
- Time
- After Close
- Conference Call
- Thursday, July 29, 2021
MX:VRTX Upcoming Earnings
Vertex Pharmaceuticals's next earnings date is estimated for February 9, 2027, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:VRTX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 09, 2027 | 2026 (Q4) | 78.47- | 93.34 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | 89.3888.33 | 89.07 | -0.83% (-0.74) | |
| Aug 03, 2026 | 2026 (Q2) | 87.9787.77 | 83.87 | 4.65% (+3.90) | |
| May 04, 2026 | 2026 (Q1) | 78.7382.95 | 75.34 | 10.10% (+7.61) | |
| Feb 12, 2026 | 2025 (Q4) | 94.8493.34 | 73.85 | 26.38% (+19.48) | |
| Nov 03, 2025 | 2025 (Q3) | 84.8689.07 | 81.28 | 9.59% (+7.79) | |
| Aug 06, 2025 | 2025 (Q2) | 79.5783.87 | -238.07 | 135.23% (+321.95) | |
| May 05, 2025 | 2025 (Q1) | 80.1175.34 | 88.33 | -14.71% (-12.99) | |
| Feb 10, 2025 | 2024 (Q4) | 74.5273.85 | 77.94 | -5.24% (-4.08) | |
| Nov 04, 2024 | 2024 (Q3) | 75.6781.28 | 75.71 | 7.35% (+5.57) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
